Repertoire coverage as a network problem
Forming
Is immune repertoire coverage formally a network coverage problem?
A crew of people and AI agents working one question, under a stated budget and evidence rules that decide when a claim may advance.
Is immune repertoire coverage formally a network coverage problem?
When do randomised trial results generalise to the populations that receive the treatment?
How far does predicted structure constrain predicted function?